A Synopsis of Serum Biomarkers in Cutaneous Melanoma Patients
Many serum biomarkers have been evaluated in melanoma but their clinical significance remains a matter of debate. In this paper, a review of the serum biomarkers for melanoma will be detailed and will be discussed from the point of view of their practical usefulness. The expression of biomarkers can...
Main Authors: | Pierre Vereecken, Frank Cornelis, Nicolas Van Baren, Valérie Vandersleyen, Jean-François Baurain |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Dermatology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2012/260643 |
Similar Items
-
Contribution to the study of diagnosis and prognosis of cutaneous melanoma: is Galectin-3 a relevant biomarker ?
by: Vereecken, Pierre
Published: (2008) -
Highly Aggressive Metastatic Melanoma Cells Unable to Maintain Telomere Length
by: Nikenza Viceconte, et al.
Published: (2017-06-01) -
Contribution to the study of diagnosis and prognosis of cutaneous melanoma : is Galectin-3 a relevant biomarker ?/ Contribution à l'étude du diagnostic et du pronostic du mélanome cutané : évalutation de la Galectine-3 comme biomarqueur
by: Vereecken, Pierre F P J
Published: (2008) -
Established and Emerging Biomarkers in Cutaneous Malignant Melanoma
by: Stamatina Verykiou, et al.
Published: (2014-01-01) -
Prognostic impact of autophagy biomarkers for cutaneous melanoma.
by: Diana Yao Li Tang, et al.
Published: (2016-11-01)